Asian Journal of Pharmaceutical Sciences Volume 20, Issue 4 2025

Title	Asian Journal of Pharmaceutical Sciences Volume 20, Issue 4 2025
Edition	Volume 20, Issue 4 2025
Call Number
ISBN/ISSN
Author(s)
Subject(s)	Cancer immunotherapy Small molecules Degraders
Classification
Series Title
GMD	Jurnal
Language	Indonesia
Publisher	China Medical University
Publishing Year	2025
Publishing Place	China
Collation
Abstract/Notes	a b s t r a c t Immunotherapy has transformed cancer treatment, marked by the approval of numerous antibody-based drugs. However,the limitations of antibodies in pharmacokinetics including long half-lives, limited oral bioavailability and immunogenicity, have prompted the pursuit of small molecule-based immunotherapy. Traditional drug discovery strategies, which focus on blocking protein activity through inhibitors, face persistent hurdles, such as reliance on accessible binding pockets, poor selectivity, and the emergence of drug resistance. Targeted protein degradation (TPD) technologies have emerged as powerful tools to address these limitations, offering significant therapeutic advantages over conventional inhibition strategies, particularly for historically ’’undruggable’’ targets. In recent years, small molecule-based protein degraders have rapidly advanced in cancer immunotherapy. In this review, we highlight recent progress in TPD-driven small-molecule drug discovery and summarize the application of these technologies in cancer immunotherapy, including degraders targeting PD-1/PD-L1, chemokine receptors, IDO1, AhR, and others.
Specific Detail Info
Image
File Attachment	LOADING LIST...
Availability	LOADING LIST...
	Back To Previous